Literature DB >> 60035

The serum protein profile in chronic hepatitis, cirrhosis and liver cancer.

S Hiramatsu, J Kojima, T T Okada, S Inai, K Ohmori.   

Abstract

Using the single radial immunodiffusion method, the serum levels of IgG, IgA, Ig M, transferrin, haptoglobin, alpha2-macroglobulin, alpha1-antitrypsin and alpha1-acid glycoprotein were estimated in healthy subjects and patients with liver diseases consisting of chronic active and inactive hepatitis, incipient cirrhosis, cirrhosis and primary liver cancer. The results obtained from the statistical analysis of the data were as follows: i) Immunoglobulins and alpha2-macroglobulin in all diseases were higher than those of healthy subjects. ii) The increased transferrin levels were found in chronic active and inactive hepatitis, and the increased alpha1-antitrypsin levels were observed in chronic inactive hepatitis, in incipient cirrhosis in cirrhosis and in primary liver cancer was higher than those of the other liver diseases. iii) Haptoglobulin levels in all diseases except for chronic inactive hepatitis were decreased. iv) alpha1-acid glycoprotein in chronic active hepatitis, in incipient cirrhosis and in cirrhosis were lower than that of healthy subjects. The evaluation of significance for difference of each protein level among disease groups clarified that the decrease of haptoglobin in cirrhosis and the increase of alpha1-antitrypsin in primary liver cancer were characteristic change respectively.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60035

Source DB:  PubMed          Journal:  Acta Hepatogastroenterol (Stuttg)        ISSN: 0300-970X


  5 in total

1.  Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function.

Authors:  L E Pedersen; J Bonde; N A Graudal; N V Backer; J E Hansen; J P Kampmann
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

2.  Kinetics of disopyramide in decreased hepatic function.

Authors:  J Bonde; N A Graudal; L E Pedersen; S Balsløv; H R Angelo; T L Svendsen; J P Kampmann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.

Authors:  R Zini; D Morin; C Salvadori; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

4.  Clinical and experimental studies on the profiles of serum proteins in acute hepatic injury.

Authors:  T Imanishi
Journal:  Gastroenterol Jpn       Date:  1981

5.  Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers.

Authors:  Akram Safaei; Afsaneh Arefi Oskouie; Seyed Reza Mohebbi; Zahra Razaghi; Naser Nejadi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.